Published: Sun, October 29, 2017
Health Care | By Gwendolyn Kim

AbbVie Inc (ABBV) Earnings


Given the stock's recent action, it seemed like a good time to take a closer look at the company's recent data. ABBV's earnings growth in the last five years was a low 5.31%, indicating a relatively more upbeat attitude towards the company in the upcoming year. The stock decreased 0.92% or $0.08 on October 27, reaching $8.6. About 724,502 shares traded. It has outperformed by 20.12% the S&P500. Looking at the stock's movement on the chart, AbbVie Inc. recorded a 52-week high of $98.26.

AbbVie Inc (AbbVie) is a research-based biopharmaceutical company.

In its bullish and bearish sentiment, the company illustrates the volatility for the week at 2.53% * with the volatility for the month at 2.17% *. About 9.07 million shares traded or 24.93% up from the average. It has underperformed by 6.07% the S&P500. Therefore 52% are positive. Eagle Pharma had 18 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was upgraded by Citigroup on Tuesday, February 23 to "Buy". New York-based Estabrook Cap Management has invested 0% in AbbVie Inc (NYSE:ABBV). Jefferies upgraded the shares of ABBV in report on Monday, December 7 to "Buy" rating. BMO Capital Markets downgraded AbbVie Inc (NYSE:ABBV) on Friday, June 10 to "Market Perform" rating. For 2018, ABBV expects EPS of $6.37 to $6.57, which could miss analysts' view of $6.59 per share for the year.

Federer beats Nadal to win Shanghai Masters title
That's the real thing, no? It moves him level with Ivan Lendl in terms of Open era titles with 94. Open, tested positive for the newly banned drug meldonium at the Australian Open in January 2016.

Landslide in Malaysia kills 3, 11 others remain under rubble
Security forces conduct a rescue operation at a construction site after a landslide in Penang, Malaysia , Saturday, Oct. 21, 2017. Meanwhile, the body of a third victim in the Tanjung Bungah landslide has also been recovered, reported The Star.

Jemele Hill: 'After my Donald Trump tweets I deserved that suspension'
The firestorm surrounding Hill began last month, when she called President Trump a " white supremacist ". I regret, a lot of the people I work with, the position we put our show in.

However, on a call with analysts, AbbVie talked up the potential of its other drugs. The stock now has a consensus rating of "Hold" and a consensus price target of $70.64. Cognios Capital Lc invested 0.09% in AbbVie Inc (NYSE:ABBV). Acropolis Investment Management LLC acquired a new stake in shares of AbbVie in the second quarter valued at approximately $106,000. It also upped Ansys Inc (NASDAQ:ANSS) stake by 2,680 shares and now owns 8,208 shares. Its up 0.01, from 0.99 in 2017Q1. It increased, as 55 investors sold ABBV shares while 581 reduced holdings. 138 funds opened positions while 500 raised stakes. Profund Advsrs Ltd holds 629,847 shares. (NYSE:ABBV) is 46.81%, 31.50% over the last quarter, and 38.28% for the past six months. Prudential owns 0% invested in Circassia Pharmaceuticals PLC (LON:CIR) for 28,247 shares. Ferguson Wellman Mngmt holds 2.05% or 751,750 shares in its portfolio. Following the completion of the sale, the chairman now directly owns 469,623 shares in the company, valued at approximately $33,343,233. Dt Invest Ltd Llc stated it has 26,469 shares. Sarissa Capital Management Lp holds 0.24% or 10,000 shares. The company has its outstanding shares of 41.98M. (PTGX) stock confirmed the flow of -0.13% with the final price of $15.57. Jpmorgan Chase & Co holds 327 shares. Moreover, Baldwin Invest Ltd Liability has 0.53% invested in AbbVie Inc (NYSE:ABBV).

Since May 4, 2017, it had 0 insider purchases, and 5 sales for $18.84 million activity. $2.88M worth of AbbVie Inc (NYSE:ABBV) shares were sold by ALBAN CARLOS. $5.59M worth of AbbVie Inc (NYSE:ABBV) shares were sold by Schumacher Laura J. Wellington Management Group Limited Liability Partnership holds 1.27M shares. First Manhattan reported 77,038 shares. Fincl Bank Of Mellon reported 277,642 shares or 0% of all its holdings. De Burlo Inc holds 0.58% or 35,675 shares in its portfolio. Oppenheimer Asset Mgmt holds 0% or 83 shares. Us Bancorp De reported 1,468 shares. Eight equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. RBC Capital Markets downgraded it to "Sector Performer" rating and GBX 105 target in Tuesday, June 21 report. RBC Capital Markets maintained the shares of MITL in report on Friday, October 9 with "Outperform" rating. The stock has "Buy" rating by Jefferies on Thursday, May 25. Piper Jaffray Companies reaffirmed a buy rating and set a $85.00 price objective on shares of AbbVie in a research report on Thursday, August 3rd. On Friday, October 13 the stock rating was maintained by UBS with "Neutral". The stock has "Sell" rating by Societe Generale on Wednesday, April 6. The rating was maintained by Morgan Stanley with "Overweight" on Friday, August 19. The firm has "Underperform" rating by Wedbush given on Tuesday, October 11.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Like this: